Menu Search

Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
Antengene Publishes Preclinical Research Paper on CD73 Small Molecule Inhibitor ATG-037 Combined with Selinexor in Cancer Gene TherapyPR Newswire
Mitsubishi Electric's New Plate Heat Exchanger Delivers 3x Conventional Heat Transfer PerformanceBusiness Wire
Aktsiaseltsi Infortar oma aktsiate omandamise tehingudGlobeNewswire
Aktsiaselts Infortar own share acquisition transactionsGlobeNewswire
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trialBusiness Wire
TAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trialBusiness Wire
Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancerPR Newswire
Enhertu® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 TrialBusiness Wire
Franco-Nevada Announces A$200 Million Follow-on Financing Package with Minerals 260 for the Bullabulling Gold ProjectCanada Newswire
Franco-Nevada Announces A$200 Million Follow-on Financing Package with Minerals 260 for the Bullabulling Gold ProjectPR Newswire
Shanghai Electric Secures First Overseas Heavy-Duty Gas Turbine Order for 500 MW Malaysian ProjectCanada Newswire
Shanghai Electric Secures First Overseas Heavy-Duty Gas Turbine Order for 500 MW Malaysian ProjectPR Newswire
Shanghai Electric Secures First Overseas Heavy-Duty Gas Turbine Order for 500 MW Malaysian ProjectPR Newswire
Element Withdraws Proposal to Acquire FleetPartners GroupCanada Newswire
Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung CancerBusiness Wire
Jazz Aviation LP and the Canadian Flight Attendant Union Reach Tentative Collective Agreement Resolving all Collective Bargaining DisputesCanada Newswire
RNS announcements are delayed by up to an hour.
...